| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 18.926 | 29.925 | 44.864 | 58.682 | 66.978 |
| Total Income - EUR | - | - | - | - | - | 18.926 | 29.925 | 44.901 | 58.682 | 66.978 |
| Total Expenses - EUR | - | - | - | - | - | 4.044 | 7.143 | 19.843 | 45.289 | 36.043 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 14.882 | 22.782 | 25.058 | 13.393 | 30.935 |
| Net Profit/Loss - EUR | - | - | - | - | - | 14.321 | 21.933 | 23.712 | 12.876 | 28.926 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dermastar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 1.486 | 1.075 | 35.226 | 41.781 | 31.496 |
| Current Assets | - | - | - | - | - | 13.664 | 35.736 | 19.239 | 20.743 | 17.926 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.132 | 9.088 | 15.567 | 18.103 | 16.151 |
| Cash | - | - | - | - | - | 12.531 | 26.649 | 3.672 | 2.639 | 1.775 |
| Shareholders Funds | - | - | - | - | - | 14.362 | 35.977 | 23.761 | 36.565 | 30.987 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 788 | 834 | 30.704 | 25.959 | 18.435 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermastar S.r.l.